Drug survival of interleukin 17 inhibitors after switch from interleukin 23 inhibitors in psoriasis: An observational cohort study

被引:0
作者
Kushnir-Grinbaum, Daniella [1 ,2 ]
Ziv, Michael [1 ]
机构
[1] Techn Inst Technol, Rappaport Fac Med, Emek Med Ctr, Dermatol Dept, Afula, Israel
[2] Sinclair Dermatol, East Melbourne, Vic, Australia
关键词
anti IL-17; anti IL-23; bio experienced; biologics; drug survival; guselkumab; IL-17; inhibitor; IL-23; interleukin-17;
D O I
10.1016/j.jaad.2024.07.1514
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:1260 / 1263
页数:4
相关论文
共 2 条
[1]   Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis [J].
Egeberg, Alexander ;
Bryld, Lars Erik ;
Skov, Lone .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) :173-178
[2]   Long-Term Effectiveness and Drug Survival of Secukinumab in Vietnamese Patients with Psoriasis: Results from a Retrospective ENHANCE Study [J].
Nguyen, Hao Trong ;
Pham, Nhi Thi Uyen ;
Tran, Tu Nguyen Anh ;
Pham, Nguyen Nhat ;
Bui, Yen Thi ;
Vu, Thao Thi Phuong .
DERMATOLOGY AND THERAPY, 2023, 13 (02) :465-476